Journal article

Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.

Bradford D Gessner, Endang R Sedyaningsih, Ulla K Griffiths, Agustinus Sutanto, Mary Linehan, Dave Mercer, Edward Kim Mulholland, Damian G Walker, Mark Steinhoff, Mardiati Nadjib

Pediatr Infect Dis J | Published : 2008


BACKGROUND: Most of Asia, including Indonesia, does not use Haemophilus influenzae type b (Hib) conjugate vaccines. We estimated total vaccine-preventable disease burden and the cost-effectiveness of Hib conjugate vaccine in Indonesia. METHODS: Hib pneumonia and meningitis incidences for children with access to health care were derived from a randomized vaccine probe study on Lombok Island, Indonesia during 1998-2002. Incidences were adjusted for limited access to care. Health system and patient out-of-pocket treatment cost data were collected concurrent with the probe study. For Hib vaccine in monovalent and combined (with DTP-HepB) presentations, we used 2007 UNICEF vaccine prices of US..

View full abstract